These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 7284427

  • 1. Pharmacokinetics and metabolism of [14C]ursodeoxycholic acid in the rat.
    Parquet M, Rey C, Groussard M, Infante R.
    Biochim Biophys Acta; 1981 Aug 24; 665(2):299-305. PubMed ID: 7284427
    [Abstract] [Full Text] [Related]

  • 2. Permeability of the rat biliary tree to ursodeoxycholic acid.
    Farges O, Corbic M, Dumont M, Maurice M, Erlinger S.
    Am J Physiol; 1989 Apr 24; 256(4 Pt 1):G653-60. PubMed ID: 2705526
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Faecal bile acid loss and bile acid pool size during short-term treatment with ursodeoxycholic and chenodeoxycholic acid in patients with radiolucent gallstones.
    Salvioli G, Salati R.
    Gut; 1979 Aug 24; 20(8):698-704. PubMed ID: 488763
    [Abstract] [Full Text] [Related]

  • 7. Metabolism of 7 beta-alkyl chenodeoxycholic acid analogs and their effect on cholesterol metabolism in hamsters.
    Une M, Yamanaga K, Mosbach EH, Tsujimura K, Hoshita T.
    J Lipid Res; 1990 Jun 24; 31(6):1015-21. PubMed ID: 2373951
    [Abstract] [Full Text] [Related]

  • 8. [Effects of ursodeoxycholic acid on the biliary lipids secretion (author's transl)].
    Yanaura S, Izuka A, Ishikawa S.
    Nihon Yakurigaku Zasshi; 1981 Oct 24; 78(4):261-7. PubMed ID: 7327454
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Metabolism and effects on cholestasis of isoursodeoxycholic and ursodeoxycholic acids in bile duct ligated rats.
    Purucker E, Marschall HU, Winograd R, Matern S.
    Biochim Biophys Acta; 2001 Apr 03; 1526(1):44-52. PubMed ID: 11287121
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of ursodeoxycholic acid on bile acid profiles and intestinal detoxification machinery in primary biliary cirrhosis and health.
    Dilger K, Hohenester S, Winkler-Budenhofer U, Bastiaansen BA, Schaap FG, Rust C, Beuers U.
    J Hepatol; 2012 Jul 03; 57(1):133-40. PubMed ID: 22414767
    [Abstract] [Full Text] [Related]

  • 15. Formation of delta 22-bile acids in rats is not gender specific and occurs in the peroxisome.
    Rodrigues CM, Kren BT, Steer CJ, Setchell KD.
    J Lipid Res; 1996 Mar 03; 37(3):540-50. PubMed ID: 8728317
    [Abstract] [Full Text] [Related]

  • 16. Enrichment of bile with tauroursodeoxycholic acid and biliary cholesterol saturation in hamsters.
    Handelsman B, Bonorris G, Marks JW, Schoenfield LJ.
    Am J Physiol; 1982 Nov 03; 243(5):G424-7. PubMed ID: 7137357
    [Abstract] [Full Text] [Related]

  • 17. Effects of Na+ replacement and amiloride on ursodeoxycholic acid-stimulated choleresis and biliary bicarbonate secretion.
    Lake JR, Van Dyke RW, Scharschmidt BF.
    Am J Physiol; 1987 Feb 03; 252(2 Pt 1):G163-9. PubMed ID: 3826345
    [Abstract] [Full Text] [Related]

  • 18. Comprehensive study of the biliary bile acid composition of patients with cystic fibrosis and associated liver disease before and after UDCA administration.
    Nakagawa M, Colombo C, Setchell KD.
    Hepatology; 1990 Aug 03; 12(2):322-34. PubMed ID: 2391071
    [Abstract] [Full Text] [Related]

  • 19. Differing effects of nor-ursodeoxycholic or ursodeoxycholic acid on hepatic histology and bile acid metabolism in the rabbit.
    Cohen BI, Hofmann AF, Mosbach EH, Stenger RJ, Rothschild MA, Hagey LR, Yoon YB.
    Gastroenterology; 1986 Jul 03; 91(1):189-97. PubMed ID: 3710068
    [Abstract] [Full Text] [Related]

  • 20. 3alpha-6alpha-Dihydroxy-7alpha-fluoro-5beta-cholanoate (UPF-680), physicochemical and physiological properties of a new fluorinated bile acid that prevents 17alpha-ethynyl-estradiol-induced cholestasis in rats.
    Clerici C, Castellani D, Asciutti S, Pellicciari R, Setchell KD, O'Connell NC, Sadeghpour B, Camaioni E, Fiorucci S, Renga B, Nardi E, Sabatino G, Clementi M, Giuliano V, Baldoni M, Orlandi S, Mazzocchi A, Morelli A, Morelli O.
    Toxicol Appl Pharmacol; 2006 Jul 15; 214(2):199-208. PubMed ID: 16487557
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.